Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects.
about
Cholesterol-induced conformational change in SCAP enhanced by Insig proteins and mimicked by cationic amphiphilesMitoxantrone-Surfactant Interactions: A Physicochemical OverviewBiomembrane models and drug-biomembrane interaction studies: Involvement in drug design and developmentExposure of chlorpromazine to 266 nm laser beam generates new species with antibacterial properties: contributions to development of a new process for drug discoveryFlavonoids in Microheterogeneous Media, Relationship between Their Relative Location and Their Reactivity towards Singlet OxygenPreliminary characterization of extracellular allelochemicals of the toxic marine dinoflagellate Alexandrium tamarense using a Rhodomonas salina bioassayIn vitro antifungal activity of organic compounds derived from amino alcohols against onychomycosis.Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization.Effect of surface roughness on inactivation of Escherichia coli O157:H7 87-23 by new organic acid-surfactant combinations on alfalfa, broccoli, and radish seeds.Using micropatterned lipid bilayer arrays to measure the effect of membrane composition on merocyanine 540 binding.Real-time detection of lipid bilayer assembly and detergent-initiated solubilization using optical cavities.Block of NMDA receptor channels by endogenous neurosteroids: implications for the agonist induced conformational states of the channel vestibule.A general mechanism for drug promiscuity: Studies with amiodarone and other antiarrhythmicsCurrent state of a dual behaviour of antimicrobial peptides-Therapeutic agents and promising delivery vectors.Structural perturbation of a dipalmitoylphosphatidylcholine (DPPC) bilayer by warfarin and its bolaamphiphilic analogue: A molecular dynamics studyBlock copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions.Building Nanostructures with Drugs.Physiological and transcriptional responses of Saccharomyces cerevisiae to d-limonene show changes to the cell wall but not to the plasma membrane.Sodium cholate aggregation and chiral recognition of the probe molecule (R,S)-1,1'-binaphthyl-2,2'-diylhydrogenphosphate (BNDHP) observed by 1H and 31P NMR spectroscopy.Electron spin resonance spectroscopy in drug delivery.Fliposomes: pH-Sensitive Liposomes Containing a trans-2-morpholinocyclohexanol-Based Lipid That Performs a Conformational Flip and Triggers an Instant Cargo Release in Acidic Medium.Red blood cell vesiculation in hereditary hemolytic anemia.Simple biological systems for assessing the activity of superoxide dismutase mimics.Interaction of local anesthetics with biomembranes consisting of phospholipids and cholesterol: mechanistic and clinical implications for anesthetic and cardiotoxic effects.Modeling the release kinetics of poorly water-soluble drug molecules from liposomal nanocarriers.Investigation on the self-association of an inorganic coordination compound with biological activity (Casiopeína III-ia) in aqueous solution.Alkylphosphocholines as Promising Antitumor Agents: Exploring the Role of Structural Features on the Hemolytic Potential.Investigating how the attributes of self-associated drug complexes influence the passive transport of molecules through biological membranes.Who is the real killer? Chlorfenapyr or detergent micelle-chlorfenapyr complex?Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80.Label-free detection of drug-membrane association using ultraviolet-visible sum-frequency generation.Surface active properties of lipid nanocapsulesEffect of 50% enantiomeric excess bupivacaine mixture combined with pancuronium on neuromuscular transmission in rat phrenic nerve-diaphragm preparation; a pilot study.Environmental stresses and clinical drugs paralyze a cell.Development and characterization of biocompatible isotropic and anisotropic oil-in-water colloidal dispersions as a new delivery system for methyl dihydrojasmonate antitumor drug.Complexities of particulate matter measurement in parenteral formulations of small-molecule amphiphilic drugsCarvedilol: solubilization and cyclodextrin complexation: a technical note.Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells.Further evaluation of quantum chemical methods for the prediction of non-specific binding of positron emission tomography tracers.Evidence of presynaptic and postsynaptic action of local anesthetics in rats.
P2860
Q24685842-EEFB4F27-93C2-4D4A-A53F-C794C7F3B134Q28066259-D13772B4-2108-4FA6-A619-22EB12C3084FQ28477404-AA6CEA84-319F-44A2-9395-5173D35AA68EQ28485991-DE454EDB-9A46-48E2-8C4E-EBC92ABE5443Q28548541-F32E42AD-D246-4DFC-88FF-1F3E2C21B5ECQ33605654-86F394D4-DB51-4112-8CD5-E116A08D5A4DQ33875150-49627D1F-B60B-484D-9734-1892C8A68DBAQ33895471-63168147-753D-4948-83EA-7E251900EAA7Q34144975-678B7F4B-90F6-4500-948F-7C1846C183DFQ34913716-C2EF5929-AEC9-456A-BE49-FB46C9648C55Q35107045-8BACE704-0806-4E2D-A0C2-5541E5FC04B1Q35754571-3FC74CEE-C665-4025-94D6-ADFCD37D45C4Q36333201-24527AE8-EEDB-4BE1-8140-30B78AA44532Q36382760-E2AD54FB-63DE-4B29-A5C6-9FD917F553E3Q36603985-4D6F7EE7-24F1-4FE4-BE48-66E0E4798D38Q36648447-31C110EE-F093-44FF-BD85-CC63D14D7EA3Q36766960-BAA2165F-2BBC-4FC9-AA56-E3DBFA2904C1Q36911204-F6CCEC8A-262C-462A-82A3-53AD423BDC09Q37250549-11221626-1A8D-4680-A687-D4738A2E02FDQ37352715-FB713126-F927-4376-9767-984F76644710Q37378137-6D21D9D1-619D-4EE6-B82A-704A0555B26FQ37389845-EEECAB29-87AF-44DA-BCCA-51EBAFC3A4E9Q37734019-20B1F638-3C56-41A1-AA72-61B4B1F12EF4Q38156766-F65F6CD1-9B74-48A9-8097-086676331AF6Q38568558-F7F4B000-4CF7-4161-9C6E-186A958436C7Q39210602-FA55569A-8369-4B23-A9D8-8D1F052B1DF6Q39531834-E89F58BD-251D-4C06-B04E-7CB03D793A84Q39930768-E073BF2D-9350-4037-9D45-BB8098AE9FFBQ40089347-D46A06AF-05ED-425B-97F8-013D917CB380Q40163020-5A0C6367-2ACC-4A68-BF27-83E5E6949FA2Q40470316-DCD11A41-B8B3-4B1A-9084-9085AD122D49Q41347662-6B027729-C385-4E3A-9761-9119975F4BE4Q41446247-0959A35D-0D09-4B00-ADDD-E84160429AA9Q41825715-4CC99010-1591-477F-989C-8112F0C7D018Q41837391-2A4EC9D4-4160-4ACF-9755-7D5139DE3F21Q41999900-2BBBAC10-6D94-4543-B937-E4FFC9B9F816Q42374191-9C5ACC91-3230-4BF0-9E1C-53947AFDBEEAQ42920496-863D1209-1C1B-4394-B166-94C133CC0F85Q44687128-0798A4F1-FEA8-4582-85C3-ABB8B13B9030Q44796446-217FA4BB-AA61-4A38-8C3E-B653582790B3
P2860
Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Surface active drugs: self-ass ...... emical and biological aspects.
@ast
Surface active drugs: self-ass ...... emical and biological aspects.
@en
Surface active drugs: self-ass ...... emical and biological aspects.
@nl
type
label
Surface active drugs: self-ass ...... emical and biological aspects.
@ast
Surface active drugs: self-ass ...... emical and biological aspects.
@en
Surface active drugs: self-ass ...... emical and biological aspects.
@nl
prefLabel
Surface active drugs: self-ass ...... emical and biological aspects.
@ast
Surface active drugs: self-ass ...... emical and biological aspects.
@en
Surface active drugs: self-ass ...... emical and biological aspects.
@nl
P2093
P1476
Surface active drugs: self-ass ...... emical and biological aspects.
@en
P2093
E de Paula
S Schreier
S V Malheiros
P304
P356
10.1016/S0304-4157(00)00012-5
P407
P577
2000-11-01T00:00:00Z